43rd week of 2008 patent applcation highlights part 52 |
Patent application number | Title | Published |
20080261787 | Method and Apparatus for Core Toning - A core toning method and apparatus allows the core muscles of the torso to be actively engaged during work day activities. The present invention recognizes that, in typical work posture, a worker leans from their chair towards a computer terminal; the mechanism of the present invention provides a resistance against the natural lean of the worker, resulting in a constant engagement of the abdominal core in order to maintain the desired posture. As will be seen from the description of various embodiments below, the concepts of the present invention may be realized in many different forms. | 2008-10-23 |
20080261788 | EXERCISE DEVICE - Various embodiments of the invention are directed towards an exercise device for use with Pilates method exercise and other exercise methods. The exercise device is used either the arms or legs of the user for various exercises. The exercise device improves upon related-art system by allowing users to performing exercises while actively engaging the hands or legs of the device with the device in a manner that remains comfortable during exercises. | 2008-10-23 |
20080261789 | Rotatable Swissball AB Trainer - The present invention provides fitness sit-up chair, which is typically comprised of a frame and an exercise ball, wherein said frame is constructed of a support and a triangle stand, said exercise ball is mounted on the foldable triangle stand. The AB trainer has easy exercising, easy folding, occupying small volume features, meanwhile facilitates to packaging, transporting and storing. | 2008-10-23 |
20080261790 | MULTI-STAGE ORIENTATING ASSEMBLY FOR AN INVERSION TABLE - A multi-stage orientating assembly for an inversion table has a stationary seat, an orientating device and an operating device. The stationary seat is connected securely to the sidewall of the table of the inversion table and has a longitudinal beam and a connecting jacket. The orientating device is connected to the mounting bracket of the inversion table and the stationary seat and has a mounting head and a clamping device. The mounting head is connected to the connecting jacket. The clamping device is connected to the stationary seat and has an engaging assembly and an orientating assembly. The operating device is connected to the stationary seat and the orientating device and has a transmitting assembly and a handle. The transmitting assembly is connected to the engaging assembly. The handle is connected securely to the transmitting assembly. | 2008-10-23 |
20080261791 | SAFETY ASSEMBLY FOR AN INVERSION TABLE - A safety assembly for an inversion table having a mounting bracket and a table connected pivotally to the mounting bracket with two pivot posts has a mounting jacket, an operating head and a fastening element. The mounting jacket is connected securely to the mounting bracket and has a mounting panel, an opening and an engaging sheet. The operating head is attached rotatably to the mounting jacket and has a connecting tube and a rotating plate. The fastening element is connected to the operating head in the mounting jacket and has a fastener, a washer and a spring. | 2008-10-23 |
20080261792 | Device for Producing Flexible Tubes from a Flat Film - The present invention relates to a device for manufacturing tubes from a flat film material, including first and second essentially concave rollers, a forming tube situated between the first and second rollers, and a longitudinal sealing device for sealing a longitudinal seam of the tube; the essentially concave rollers each include a multitude of individual disks mounted for free rotation relative to one another about a common axis. | 2008-10-23 |
20080261793 | METHOD FOR ERECTING TUBULAR BLANKS AND A STATION, IN WHICH THIS METHOD IS CARRIED OUT - A station for erecting tubular blanks in boxes, a gripping and raising unit engages a second lateral wall of the blank and subsequently raises the blank into a 90° rotation, so that the blank assumes, due to raising and rotating and because of the weight, a parallel-piped shore with a vertical axis. A first holder is operated by a first actuator in step relation with rotation of the blank and folds at least a first lateral wall of the blank adjacent to the second lateral wall, engaged by the gripping unit, to erect, the blank in a box with vertical axis. | 2008-10-23 |
20080261794 | Cutting Device For Cushioning Dunnage Producing Machine - A cushioning dunnage producing machine comprises a crumpler, a roll of paper sheet material having a first end at a radially innermost location and a second end at a radially outermost location, the first end fed into the crumpler, the crumpler drawing the paper sheet from the roll and crumpling the paper sheet into cushioning dunnage, and a cutter which travels laterally across the cushioning dunnage to cut the dunnage into a strip of a desired length. | 2008-10-23 |
20080261795 | FRITS AND OBSCURATION ENAMELS FOR AUTOMOTIVE APPLICATIONS - Frits, obscuration enamel compositions including frits and automotive windshields having obscuration enamel compositions applied thereto are described. According to one or more embodiments, the obscuration enamel composition comprises a paste component and a frit component having Bi | 2008-10-23 |
20080261796 | RESISTANCE PASTE FOR HIGH-POWER THICK FILM CIRCUITS BASED ON A STAINLESS STEEL SUBSTRATE AND PREPARATION METHOD THEREOF - The present invention relates to a resistance paste for a high-power thick film circuit based on a stainless steel substrate and a preparation method thereof The resistance paste disclosed in the present invention demonstrates a low resistivity, excellent insulating performance, superior printing and sintering characteristics, and good compatibility with a surface-insulated stainless steel substrate. The preparation method of the present invention comprises steps of: A. Preparing a microcrystalline glass powder; B. Preparing an organic binder; C. Formulating a paste: preparing a solid-phase component with the silver powder, the palladium powder and the microcrystalline glass powder in appropriate proportions; mixing in a ball mill tank the solid-phase component and the organic binder in an appropriate proportion; and putting the resultant mixture into a ball mill to be grounded therein. In the present invention, a microcrystalline glass is selected as a binding phase, and a resistance trace layer made therefrom exhibits an expansion coefficient compatible with the stainless steel and can be well bonded with the stainless steel. The resistance trace layer thus obtained has advantages of low resistance, good compatibility with dielectric materials and electrode pastes used in thick film circuits based on a stainless steel substrate, and satisfactory conductivity. | 2008-10-23 |
20080261797 | Optical glass for press molding and optical element - The optical glass for press molding of the present invention contains 35 to 45% by weight of SiO | 2008-10-23 |
20080261798 | Amber Glass - A colored glass has a formula of R′ | 2008-10-23 |
20080261799 | Refractory shaped body with increased alkali resistance - The invention relates to a refractory batch and to a process for its production. The batch comprises a refractory metal oxide main component containing Al | 2008-10-23 |
20080261800 | EROSION RESISTANCE ENHANCED QUARTZ USED IN PLASMA ETCH CHAMBER - A method of fabricating doped quartz component is provided herein. In one embodiment, the doped quartz component is a yttrium doped quartz ring configured to support a substrate. In another embodiment, the doped quartz component is a yttrium and aluminum doped cover ring. In yet another embodiment, the doped quartz component is a yttrium, aluminum and nitrogen containing cover ring. | 2008-10-23 |
20080261801 | Methods of Regenerating a Nox Absorbent - An exhaust system for a lean-burn internal combustion engine with at least one NO | 2008-10-23 |
20080261802 | Cracking Catalyst and a Preparation Process for the Same - The present invention provides a cracking catalyst, containing a rare-earth Y-zeolite and a support, which is characterized in that the rare-earth content in crystal lattice of the rare-earth Y-zeolite is 4-15 wt % of RE | 2008-10-23 |
20080261803 | Modified Zeolite Beta - A modified zeolite beta having an anhydrous chemical formula, by weight % of the oxides, of (0-0.3)Na | 2008-10-23 |
20080261804 | Oxygen-Bridged Bimetallic Complex, the Production Thereof and Its Utilization for Polymerization Catalysis - The binoclear, oxygen-bridged, hetero-bimetallic complexes of general formula [(LM | 2008-10-23 |
20080261805 | Photocatalytic Titanium Dioxide Microparticle, Dispersion Liquid Thereof and Process for Producing the Same - Photocatalytic titanium dioxide particles are disclosed having improved dispersibility into an aqueous solvent not only under neutral physiological conditions in vivo but also over a wide pH range, and improved cell affinity and cell uptake property. The photocatalytic titanium dioxide particles comprise particles comprising photocatalytic titanium dioxide and a cationic hydrophilic polymer modifying surfaces of the photocatalytic titanium dioxide particles, wherein the hydrophilic polymer is bonded to the photocatalytic titanium dioxide particles. The photocatalytic titanium dioxide particles are very useful for medical applications, such as destruction of cancer cells. | 2008-10-23 |
20080261806 | CATALYST SUPPORTING HONEYCOMB AND METHOD OF MANUFACTURING THE SAME - A catalyst supporting honeycomb includes a pillar-shaped honeycomb structure and catalyst particles supported on the honeycomb structure. The honeycomb structure includes cell walls extending in a longitudinal direction of the honeycomb structure to define a plurality of cells extending in the longitudinal direction. The plurality of cells include large-volume cells having first opening ends and second closing ends opposite to the first opening ends along the longitudinal direction, and small-volume cells having first closed ends and second opening ends opposite to the first closed ends along the longitudinal direction. Total cross sectional areas of the large-volume cells on a plane perpendicular to the longitudinal direction are larger than total cross sectional areas of the small-volume cells on the plane. The catalyst particles include an oxide catalyst having an average particle diameter of at least about 0.05 μm and at most about 1.00 μm. | 2008-10-23 |
20080261807 | Polysaccharide-Inorganic Composite Particles as Performance Additives for Superabsorbent Polymers - The present invention relates to discrete particulate composite additives for superabsorbent polymers and includes a method of making same. The discrete particulate composite additives generally comprise a polysaccharide and an inert inorganic component. Advantageously, these discrete particulate composite additives functionally improve superabsorbent performance. They are suitable for a number of applications, including the use and manufacture of hygiene products. | 2008-10-23 |
20080261808 | Recordable medium with template pattern - A recordable medium having a data side and a label side has one or more template patterns printed on the label side, and has at least first indicia including a template-reference-position mark. | 2008-10-23 |
20080261809 | Encoder spokes detection prior to forming image on optically writable label surface of optical disc - Whether an optically writable label surface of an optical disc is suitable for having an image formed thereon is determined. A detectable number of encoder spokes on a control feature area of the optical disc is counted as the optical disc is rotated. Where the detectable number of encoder spokes is other than a predetermined value, an error condition with respect to the optically writable label surface of the optical disc is indicated. | 2008-10-23 |
20080261810 | Insecticides Based on Neonicotinoids and Safeners - Insecticidal compositions, characterized by an effective amount of a combination of active compounds comprising
| 2008-10-23 |
20080261811 | Synergistic Mixtures Exhibiting Insecticidal and Fungicidal Action - The present invention relates to novel active compound combinations comprising as active compounds firstly an active compound from the group of the neonicotinoids and, secondly, at least one active compound selected from the group of the amino acid derivatives benalaxyl M and metalaxyl M, to their use as pesticides and seed dressings for the treatment of seed, to methods for controlling pests and for protecting seed and to seed treated with the active compound combinations according to the invention. | 2008-10-23 |
20080261812 | Pesticidal Mixtures - Pesticidal mixtures comprising, as active components, | 2008-10-23 |
20080261813 | Sugarcane Harvest Aid - Protoporphyrinogen oxidase enzyme-inhibiting compounds are useful in compositions and methods for ripening sugarcane crops. Of particular interest is the use of carfentrazone ethyl and certain metabolites thereof for ripening sugarcane crops. | 2008-10-23 |
20080261814 | Alkoxylated Alkylamines/Alkyl Ether Amines With Peaked Distribution - The present invention generally relates to a process for preparing the alkoxylated alkylamines and/or alkyl ether amines. The process consists of three stages, and utilizes an alkali catalyst. The alkoxylated alkyl amines and alkoxylated alkyl ether amines prepared by the process possess the peaked distribution and contain less hazardous by-product. | 2008-10-23 |
20080261815 | Bioherbicide from Festuca Spp - The present invention relates to methods of using m-tyrosine compounds from | 2008-10-23 |
20080261816 | ACTIVE AGENT CELLULOSIC CARRIER GRANULE - An inventive flowable granular material for adhesion to foliage is provided, which material includes peanut hull fragments as a preferably majority lightweight component, a heavy weight component mixed therewith to improve the flowability of the resultant granular material, and a solvent to aid in the transfer of the foliar active agent to a leaf surface and foliar adhesion. Related particle size distributions and densities are described. Also provided is a process for promoting plant growth comprising: broadcast distributing the inventive flowable granular material to adhere to foliar surfaces; and releasing the foliar active agent onto the foliar surface. | 2008-10-23 |
20080261817 | Methods for Analyzing Global Regulation of Coding and Non-Coding RNA Transcripts Involving Low Molecular Weight RNAs - In some embodiments of the invention, methods are provided to interrogate the transcriptional activity relating to RNAs of small molecular weight. The methods employ hybridization of a large number of oligonucleotide probes with nucleic acid derived from RNAs of small molecular weight. | 2008-10-23 |
20080261818 | Methods of Identifying Pancreatic Cancer Cells - Methods that identify cells as pancreatic cancer cells based on assessing the expression of combinations of target molecules expressed preferentially on pancreatic cancer cells are disclosed. Combinations were initially discovered by microarray analysis and selected based upon tumor specificity, relative lack of cross-reactivity with normal tissues, and applicability as targets of multispecific ligands. The claimed methods encompass measuring the expression of three or more specific target molecules in combination and correlating positive expression of the combination with an identification of the cell as a pancreatic cancer cell. | 2008-10-23 |
20080261819 | IN VIVO PRODUCTION OF CYCLIC PEPTIDES FOR INHIBITING PROTEIN-PROTEIN INTERACTION - The present invention relates to methods and compositions utilizing inteins to generate libraries of cyclic peptides in vivo. The prevent invention also relates to methods for inhibiting protein-protein interaction. | 2008-10-23 |
20080261820 | Methods to Analyze Biological Networks - The present invention relates to a family of graph-theory based methods for the analysis of intracellular signaling networks created from biomedical literature using data-mining processes or acquired through high-content experiments. The methods of the present invention can be used to identify functional dynamic modules within biological networks that can be analyzed quantitatively for input/output relationships. In particular, the present invention relates to a computer-aided method for the in-silico analysis of signaling and other cellular interaction pathways to rank drug targets, identify biomarkers, predict side effects, and classify/diagnose patients. | 2008-10-23 |
20080261821 | Mechanism-Based Crosslinkers - The present invention provides novel mechanism-based crosslinkers useful in covalently linking a kinase and an interactor. | 2008-10-23 |
20080261822 | Non-invasive prenatal genetic diagnosis using transcervical cells - A non-invasive, risk-free method of prenatal diagnosis is provided. According to the method of the present invention transcervical specimens are subjected to trophoblast-specific immuno-staining followed by FISH, PRINS, Q-FISH and/or MCB analyses and/or other DNA-based genetic analysis in order to determine fetal gender and/or identify chromosomal and/or DNA abnormalities in a fetus. Also provided is a method of in situ chromosomal, DNA and/or RNA analysis of a prestained specimen by incubating the prestained specimen in ammonium hydroxide. Also provided is a method of identifying embryonic cells according to a nucleus/cytoplasm ratio of at least 1:1 and the presence of at least variably condensed chromatin. | 2008-10-23 |
20080261823 | Fluorescent Nucleoside Analogs That Mimic Naturally Occurring Nucleosides - The present invention provides fluorescent nucleoside analogs with conjugated membered heterocycles, including furan and thiophene. The fluorescent nucleoside analogs maintain structural similarity to naturally occurring nucleoside bases, mimicking shape, size, hybridization, and recognition properties. Incorporation of the fluorescent cyclic compounds confers specific photophysical characteristics including a bathochromic (red) shift of the absorption spectrum to minimize absorption overlap with naturally occurring nucleoside bases, and a shift to the long emission wavelength in the visible range. The invention also provides for various methods of synthesizing the fluorescent nucleoside analogs and incorporating the fluorescent analogs in DNA, RNA, or oligomer synthesis. Further, methods of detecting the fluorescent nucleoside analogs in an oligonucleotide or oligomer are provided. The subject compounds are useful as probes in the study of the structure and dynamics of nucleic acids and their complexes with proteins. | 2008-10-23 |
20080261824 | Rationale, methods, and assays for identifying novel taste cell genes and salty taste receptor targets and assays using these identified genes or gene products - This invention relates to novel rationale and methods for identifying taste-specific genes, including genes involved in salty taste perception, especially human salty taste perception, but also genes involved in sweet, bitter, umami, and sour taste perception, and genes involved in other taste cell or taste receptor related activities such as digestive function and digestive related diseases, taste cell turnover, immunoregulation of the oral and digestive tract, and metabolic regulation such as in diabetes and obesity, the genes identified using these methods, and assays for identifying taste modulators (enhancers or blockers) and potential therapeutics using these genes. These compounds have potential application in modulating (enhancing or blocking) taste perception, especially salty taste perception and as potential therapeutics. In addition, this invention relates to novel methods for identifying taste-specific genes that can be used as markers for different taste cell types, including sweet, bitter, umami, sour, salt, and other taste cells in mammals as well as assays that measure the activity of the sweet, bitter, umami, or sour receptor in the presence of these genes to identify modulators of sweet, bitter, umami, and sour taste and to identify therapeutics especially for treating digestive or metabolic disorders, taste loss, and oral infections. Further, the invention provides specific methods of purifying, enriching, isolating or marking desired taste cell subtypes or lineages such as sweet, umami, bitter, salty, sour, fat or stem cells et al. e.g., by use of FACS, magnetic beads or other selection methods that purify, enrich, mark, or eliminate such as by use of labeled cytotoxins, cells that express or do not express one or more taste specific genes. | 2008-10-23 |
20080261825 | METHOD OF IMMOBILIZING MEMBRANE-ASSOCIATED MOLECULES - The present invention relates to methods of immobilizing membrane-associated molecules within a sol-gel matrix. The membrane-associated molecule is embedded in the bilayer of a liposome. The molecule-liposome assembly remains functionally intact when it is immobilized within a protein and membrane-compatible sol-gel derived from polyol silane precursors or sodium silicate. The activity and stability of the entrapped membrane-associated molecule was significantly improved in macroporous silica. | 2008-10-23 |
20080261826 | Manufacture And Use Of Non-Standard Size Microarray Slides - Methods and devices are disclosed for microarray analysis. In one embodiment a method is disclosed for processing a non-standard size slide having an array of chemical compounds attached to a surface of the slide. A sample is exposed to the surface of the non-standard size slide wherein components in the sample bind to the chemical compounds on the surface of the slide. The sample and the slide are incubated under conditions for carrying out the binding reactions, and the surface of the non-standard size slide is examined for the results of the binding reactions. Prior to the exposing step or the incubating step or the examining step, the non-standard size slide is placed into a slide holder comprising a slide-holding section a slide-holding section adapted to dispose the non-standard size slide to a processing instrument in a manner similar to that for a standard size slide. The non-standard size slide may also include an identifier such as a bar code. | 2008-10-23 |
20080261827 | Detection And Analysis System For Protein Array - To provide a method for detecting a protein by immobilizing a protein on a protein array substrate at a high density with controlled orientation, irradiating the immobilized protein with ultraviolet light, visible light, or infrared light, and measuring the light not absorbed by the protein and further analyzing an interaction between the protein on the substrate and another protein and/or a compound other than proteins, a system used for the method, and to provide a protein array suitable for the system. A system including a protein array in which a protein is immobilized in aligned position on a light-transmissive substrate at a high density, a light-irradiating means, and a light-detecting means and being for detecting or analyzing a protein on the protein array and/or a compound which is other than proteins and interacts with the immobilized protein, wherein the protein array is irradiated with light by the light-irradiating means, and the light transmitted through the protein array is measured by the light-detecting means for detecting the light absorption of the protein on the protein array and/or the compound which is other than proteins and interacts with the immobilized protein. | 2008-10-23 |
20080261828 | Quantum Dot Template for Fast and Simultaneous Detection of Different Infectious Agents - A method and a device for detecting the presence of a predetermined substance, in which a quantum dot is produced on a substrate. The quantum dot emits a radiation at a predetermined wavelength, and is covered with a surface layer to which the predetermined substance attaches. A deviation of the value of a parameter related to the radiation is produced when the predetermined substance attaches to the surface layer. This deviation can be detected to thereby sense the presence of the predetermined substance. | 2008-10-23 |
20080261829 | ANTIBODY-BASED ARRAYS FOR DETECTING MULTIPLE SIGNAL TRANSDUCERS IN RARE CIRCULATING CELLS - The present invention provides antibody-based arrays for detecting the activation state and/or total amount of a plurality of signal transduction molecules in rare circulating cells and methods of use thereof for facilitating cancer prognosis and diagnosis and the design of personalized, targeted therapies. | 2008-10-23 |
20080261830 | Probe Array Base, Method for Manufacturing Probe Array Base, Method for Manufacturing Probe Array - A probe array base including probe-holding portions which are periodically arranged on a solid base member and which have grooves is prepared by anisotropically etching a single-crystalline silicon substrate. Probe solutions are supplied to the probe-holding portions by capillary action from a plurality of tank arrays having a certain cylinder period. This allows a probe array to be completed. The probe array is used as, for example, a DNA or antigen chip, has a high degree of integration, and is capable of holding a constant and sufficient number of probe molecules. | 2008-10-23 |
20080261831 | Ligands and libraries of ligands - The invention relates to variants of Target Biological Molecules (TBMs), such as proteins, peptides and other amino acid sequences that are modified to include cysteine residues at predetermined positions within the TBM. The position of amino acid residues within the TBM that are modified to be cysteine residues is selected for its proximity to ligand binding sites within the TBM. Once an amino acid residue, or the DNA encoding the residue, is modified to cysteine, the TBM linked to potential binding ligands by forming a covalent bond through the cysteine thiol (—SH) reactive group of the variant. | 2008-10-23 |
20080261832 | Arrays of nucleic acid probes for detecting cystic fibrosis - The invention provides arrays of immobilized probes, and methods employing the arrays, for detecting mutations in the CFTR gene. | 2008-10-23 |
20080261833 | METHODS FOR GENERATING POLYNUCLEOTIDES HAVING DESIRED CHARACTERISTICS BY ITERATIVE SELECTION AND RECOMBINATION - A method for DNA reassembly after random fragmentation, and its application to mutagenesis of nucleic acid sequences by in vitro or in vivo recombination is described. In particular, a method for the production of nucleic acid fragments or polynucleotides encoding mutant proteins is described. The present invention also relates to a method of repeated cycles of mutagenesis, shuffling and selection which allow for the directed molecular evolution in vitro or in vivo of proteins. | 2008-10-23 |
20080261834 | Method and Composition for Treatment of a Well - The invention provides a material comprising: a core made of a solid material; a first layer surrounding the core made of a swellable material able to swell in contact with a fluid ; a second layer surrounding the first layer made of a glue material able to glue to a third element. | 2008-10-23 |
20080261835 | Surfactant based compositions and process for heavy oil recovery - A process for recovering heavy oil with the steps of: a) injecting into one or more injection wells an aqueous injection fluid containing one or more surfactants designed to form a pseudo-emulsion between the injection fluid and the heavy oil, and, b) recovering the oil from one or more producing wells. The process does not require the addition of outside mechanical or thermal energy or solvents to recover the heavy oil and does not form emulsions between the injection fluid and the heavy oil that may be difficult to break when brought to the surface or may cause increased viscosity and injectivity problems within the reservoir. | 2008-10-23 |
20080261836 | Compositions for use in well servicing fluids - A composition useful in a well servicing fluid comprising a base fluid, comprising from 5-40 wt. % paraffins, from 5-40 wt. % olefins, from 5-20 wt. % naphthenes, from 5-20 wt. % esters, and from 2-10 wt. % oxygenates comprising primarily alcohols and ethers, the base fluid being useful as an additive alone or in conjunction with at least one other component typically used in well servicing fluids such as drilling fluids, workover fluids, packer fluids, etc. | 2008-10-23 |
20080261837 | Low-Density Ceramic Proppant and Its Production Method - A low-density ceramic proppant is formed from a light aggregate of a natural mineral and a ceramic binding material in the form of a proppant granule. The light aggregate expands in volume when burnt so that the density of the aggregate is changed. A method of preparing a proppant material is carried out by pre-crushing and pre-mixing of raw components. This is followed by their granulation into proppant granules, drying and screening of the granules to a selected size. The raw components include at least a ceramic binding material and a light aggregate of a natural mineral that, when burnt, expands in volume so that the specific volume of the aggregate is changed. The burning of the light aggregate may be accomplished before or after the aggregate is mixed with the binding material. | 2008-10-23 |
20080261838 | SYNERGISTIC ORGANOBORATE COMPOSITIONS AND LUBRICATING COMPOSITIONS CONTAINING SAME - An additive for imparting antiwear properties to a lubricant composition is based on a combination of (1) an organo borate ester composition and (2) one or more sulfur- or phosphorus-containing compounds or a non-sulfur molybdenum compound. The sulfur- or phosphorus-containing compounds are dithiocarbamate, bisdithiocarbamate, 1,3,4-diathiazole, phosphorodithioate, phosphorodithioate esters, and the molybdenum compound is prepared by reacting (a) about 1.0 mole of fatty oil having 12 or more carbon atoms, (b) about 1.0 to 2.5 moles diethanolamine and (c) a molybdenum source. | 2008-10-23 |
20080261839 | ODOR REDUCTION FOR AGENTS CONTAINING HYPOCHLORITE - The aim of the invention is to diminish the odor, often perceived as unpleasant, that is left behind on human skin, in particular on the hands as a result of contact with agents containing chlorine bleach after use of the agent. This was achieved by the use of odorants selected from the group comprising diphenylmethane, diphenyl oxide, 2-methyl naphtyl ether, and mixtures thereof. | 2008-10-23 |
20080261840 | Remediation of Microfloral and Biofilm Development From Laundering Devices - Methods, improved compositions and kits are employed that provide dosing and cleaning solutions containing a halogen-based oxidant effectively delivered to remediate microfloral and biofilm development on the laundering surfaces of enclosed horizontal axis washers. The improved compositions, and the methods and kits employing them, provide for effective remediation while minimizing and/or preventing detrimental effects upon halogen-susceptible surfaces of the laundering devices, including reduced corrosion and biofilm on interior metal and laundering surfaces. | 2008-10-23 |
20080261841 | BIGUANIDE COMPOSITION WITH LOW TERMINAL AMINE - A polymeric biguanide composition comprising less than 18 mol % of terminal amine groups as measured by | 2008-10-23 |
20080261842 | Cleaning composition - A post-foaming personal cleaning composition in the form of a gel for use in an aerosol container. This composition includes a base material of a surfactant in an amount not less than 7% by weight and a thickener that is a blend of at least one of glyceryl ester, and a glyceryl ester derivative with at least one of a betaine and a gum. The base material preferably has a viscosity greater than 9,500 cps. The composition also includes a foam forming material, above 9% by weight of the composition with at least a part of the foam forming material being maintained in suspension in the composition until after the composition is dispensed from the aerosol container. The foam forming material is preferably a saturated aliphatic hydrocarbon having from 4 to 5 carbons and the composition is in the form of a gel prior to inclusion of the foam forming material. | 2008-10-23 |
20080261843 | BAR COMPOSITION COMPRISING THERMOCHROMIC PIGMENT OR DYE SIGNALLING BENEFIT AGENT RELEASE OR OTHER USE - The invention relates to bar compositions comprising thermochromatic pigment or dye signaling temperature and/or benefit agent release. In a preferred embodiment, the pigment is introduced in the form of a separate domain (e.g., separate chips) which separate chip or chips is combined with a surfactant-containing chips to form the final bar. | 2008-10-23 |
20080261844 | Multicolor Cosmetics - Multicolored cosmetic preparation containing
| 2008-10-23 |
20080261845 | SKIN CLEANSING COMPOSITIONS - A skin cleansing composition contains the following ingredients (A), (B) and (C):
| 2008-10-23 |
20080261846 | Compositions for the Removal of Post-Etch and Ashed Photoresist Residues and Bulk Photoresist - The invention provides cleaning compositions for cleaning microelectronic substrates that are able to essentially completely clean such substrates and inhibit metal corrosion or produce essentially no corrosion of the metal elements of such substrates, and to do so at relatively short cleaning times and relatively low temperatures compared to the cleaning times required for prior art alkaline-containing cleaning compositions. The invention also provides method of using such cleaning compositions to clean microelectronic substrates without producing any significant corrosion of the metal elements of the microelectronic substrate. The cleaning compositions of this invention comprise (a) at least one organic solvent, (b) at least one unneutralized inorganic phosphorus-containing acid, and (c) water. The cleaning compositions of this invention optionally can have present in the compositions other components, such as for example surfactants, metal complexing or chelating agents, corrosion inhibitors, and the like. The cleaning compositions of this invention are characterized by an absence of organic amines, hydroxylamines or other strong bases such as ammonium bases and the like that would neutralize the inorganic phosphorus-containing acid component. The cleaning and residue removal compositions of this invention are especially suitable for cleaning microelectronic substrates containing aluminum, titanium, and tungsten. | 2008-10-23 |
20080261847 | Composition and Method for Recycling Semiconductor Wafers Having Low-K Dielectric Materials Thereon - A removal composition and process for removing low-k dielectric material, etch stop material, and/or metal stack material from a rejected microelectronic device structure having same thereon. The removal composition includes hydrofluoric acid. The composition achieves at least partial removal of the material(s) from the surface of the microelectronic device structure having same thereon, for recycling and/or reuse of said structure, without damage to the underlying polysilicon or bare silicon layer employed in the semiconductor architecture. | 2008-10-23 |
20080261848 | Multifunctional Material Compositions and Methods - A compound for use in a detergent composition is provided that has formula X(SiO | 2008-10-23 |
20080261849 | Composition - A dishwasher detergent composition, preferably pH neutral, and comprising a strong biodegradable builder and optionally a bleach, and optionally a sulfonated polymer. | 2008-10-23 |
20080261850 | Laundry Product - A unit dose fabric treatment system comprises a water soluble container in which a liquid fabric treatment composition is disposed, the composition comprising a fatty acid and an alkylated sugar. | 2008-10-23 |
20080261851 | PACKAGING SYSTEM FOR DETERGENTS OR CLEANSERS - Packaging systems for detergent or cleanser dosing units comprising: a) a primary packaging system in the form of a number (n)>2 of water-insoluble bags, each of these bags containing a number (x)>2 of detergent or cleanser dosing units, and; b) a secondary packaging system in the form of a water-insoluble bag that contains the (n) water-insoluble bags of the first packaging system. The inventive packaging systems are suited for increasing the stability of the detergent or cleanser dosing units contained therein. | 2008-10-23 |
20080261852 | Bleach Reinforcer Combination for Use in Washing and Cleaning Agents - The performance of peroxide compounds, in particular when associated with bleaches for washing ink stains out of textiles, can be improved by a composition comprising: (i) a peroxygen-containing bleaching agent, (ii) a bleach activator selected from the group consisting of amide bleach activators, sulfonyl phenyl ester bleach activators, quaternary nitrogen substituted acetonitrile bleach activators, and mixtures thereof, and (iii) a compound selected from the group consisting of ligands corresponding to the general formula (I), bleach catalysts corresponding to the general formula (II), and mixtures thereof: | 2008-10-23 |
20080261853 | Surface Active Polymers as Detergents - Provided herein are compositions useful as detergents in cleaning a wide variety of substrates, including hard surfaces and laundry. The compositions contain a water-soluble polymer, which is a co-polymer between a polymerizable amide and a second, ethylenically-unsaturated monomer. The polymerizable amide itself is prepared from an amine-capped, alkoxylated alcohol by reaction with maleic acid anhydride. Compositions according to the invention show enhanced cleaning performance and beneficial anti-redeposition properties. | 2008-10-23 |
20080261854 | Spray-drying process for preparing a low density, low builder, highly water-soluble spray-dried detergent powder - The present invention relates to a spray-drying process for the preparation of a spray-dried detergent powder having a bulk density of 426 g/l or less, wherein the spray-dried detergent powder comprises an anionic detersive surfactant and from 0 wt % to 10 wt % zeolite builder and from 0 wt % to 10 wt % phosphate builder, and wherein the process comprises the step of: (a) preparing an aqueous slurry suitable for spray-drying comprising from 30 wt % to 60 wt % water and from 40 wt % to 70 wt % non-aqueous material, wherein the non-aqueous material comprises an inorganic component and an organic component, wherein the weight ratio of the inorganic component to organic component is in the range of from 0.3:1 to 5:1; and (b) spraying the slurry into a spray-drying tower, wherein the temperature of the slurry as it enters the spray-drying tower is in the range of from 65° C. to 140° C., and wherein the outlet air temperature of the spray-drying tower is in the range of from 70° C. to 120° C. | 2008-10-23 |
20080261855 | Bleaching composition comprising an alkoxylated benzoic acid - The present invention relates to a liquid bleaching composition comprising a hypohalite bleach, a trimethoxy benzoic acid or a salt thereof and a compound selected from the group consisting of bleach-unstable brighteners, and bleach-unstable coloring-agents and mixtures thereof. | 2008-10-23 |
20080261856 | Detergent for Hard Surfaces - The invention relates to a detergent for hard surfaces, which contains (a) a polymer compound having a cationic group, such as a cation-modified polyvinyl alcohol containing specified structural units, (b) a surfactant and (c) water. | 2008-10-23 |
20080261857 | Targeted Granulation Achieved by Neutralisation in a Compomix-Type Machine - Methods for manufacturing surfactant granules, which methods comprise: (a) neutralizing an anionic surfactant acid with a solid neutralization agent, wherein the anionic surfactant acid has a water content of 5 to 24 wt %, and wherein the anionic surfactant acid and the solid neutralization agent are agglomerated in a free-fall mixer, to form surfactant granules having a bulk density of 300 to 800 g/l, are described. | 2008-10-23 |
20080261858 | Fragrance Compositions - An eau de Cologne composition that comprises a water-soluble polyurethane and a low molecular weight water-soluble saccharide. Preferably the polyurethane is Polyurethane-1 and the saccharide sucralose. A dried film of the composition on the skin releases a burst of fragrance when wetted, for example by licking or kissing, and in addition tastes pleasant and does not become sticky. | 2008-10-23 |
20080261859 | 4-Hepten-2-Yl Salicylate and Its Use as Fragrance Ingredient - The present invention is related to 4-hepten-2-yl salicylate and its use as fragrance ingredient. | 2008-10-23 |
20080261860 | 2-Methoxy-2, 6-Dimethyloctanal and Its Use as a Fragrance Ingredient - 6-Methoxy-2,6-dimethyloctanal, a method of its production and fragrance compositions comprising it. | 2008-10-23 |
20080261861 | 2-Micron Family Plasmid and Use Thereof - The present invention provides a 2 μm-family plasmid comprising a polynucleotide sequence insertion, deletion and/or substitution between the first base after the last functional codon of at least one of either a REP2 gene or an FLP gene and the last base before the FRT site in an inverted repeat adjacent to said gene. | 2008-10-23 |
20080261862 | Materials and Methods for Modulating Signalling by Alpha-V Integring Molecules - It is disclosed that the αvβ5 integrin mediates the proliferative signal provided by CD23 to pre-B cells. The region of CD23 which interacts with αvβ5 has been defined, and found to interact with a site on the integrin distinct from that which binds RGD. The invention provides methods for disrupting the interaction between CD23 and αvβ5 and methods of screening for chemical entities capable of disrupting this interaction. | 2008-10-23 |
20080261863 | Pegylation of Vasoactive Intestinal Peptide (Vip) / Pituitary Adenylate Cyclase Activating Peptide (Pacap) Receptor 2 (Vpac2) Agonists and Methods of Use - This invention relates to modified Vasoactive Intestinal Peptide (VIP)/Pituitary Adenylate Cyclase Activating Peptide (PACAP) Receptor 2 (VPAC2) agonists (VPAC2 agonists) comprising a VPAC2 agonist linked to a polyethylene glycol polymer, as well as related formulations, dosages, and methods of administration thereof for therapeutic purposes. These VPAC2 agonists, compositions, and methods are useful in providing a treatment option for those individuals afflicted with a metabolic disorder such as diabetes, impaired glucose tolerance, metabolic syndrome, or prediabetic states, by inducing glucose-dependent insulin secretion in the absence of the therapeutically limiting side effect of reducing or lowering blood pressure. | 2008-10-23 |
20080261864 | Combination of nateglinide or repaglinide with at least one further antidiabetic compound - The present invention relates to a combination of organic compounds which comprises at least two antidiabetic agents, preferably with different modes of action, in which the active ingredients are in each case present in free form or in the form of a pharmaceutically acceptable salt and, optionally, at least on pharmaceutically acceptable carrier, for simultaneous, separate or sequential use. | 2008-10-23 |
20080261865 | Oxidized Lipids and Uses Thereof in the Treatment of Inflammatory Diseases and Disorders - Novel synthetic oxidized lipids and methods utilizing oxidized lipids for treating and preventing an inflammation associated with an endogenous oxidized lipid are provided. | 2008-10-23 |
20080261866 | Compositions Comprising Glycosaminoglycan and Nonsteroidal Anti-Inflammatory Drug - Pharmaceutical compositions comprising of glycosaminoglycan or salts thereof, preferably chondroitin or salts thereof, more preferably chondroitin sulphate, and nonsteroidal anti-inflammatory drug(s) or salts thereof, optionally with pharmaceutically acceptable excipient(s) are described. The compositions of the present invention provide gastrosparing effect in conditions where nonsteroidal anti-inflammatory drug(s) or their salts are used, particularly in mammals. Also provided are process for the manufacture of such novel compositions and method to minimize the nonsteroidal anti-inflammatory drug(s) induced gastric toxicity. | 2008-10-23 |
20080261867 | Soluble inhibitors of vascular endothelial growth factor and use thereof - The present invention relates to cDNA encoding a soluble neuropilin protein (sNP) which is isolated from neuropilin (NP) producing cells or is recombinantly engineered from NP-encoding DNA. NP-1 and NP-2 are preferred NPs but any neuropilin or VEGF receptor (VEGFR), where the constituents share at least about 85% homology with either of the above VEGF | 2008-10-23 |
20080261868 | Methods and Compositions for Treating Diabetes - The instant invention provides a method of treating an animal suffering a disease characterized by excessive apoptosis by administering a therapeutically effective amount of at least one serine protease inhibitor and thereafter monitoring a decrease in apoptosis. The inhibitor of the invention includes α | 2008-10-23 |
20080261869 | COMPOSITIONS AND METHODS OF USE FOR ALPHA-1 ANTITRYPSIN HAVING NO SIGNIFICANT SERINE PROTEASE INHIBITOR ACTIVITY - Embodiments herein illustrate methods and compositions for treating medical disorders. In certain embodiments, compositions and methods relate to reducing, inhibiting or treating a bacterial infection, or a viral infection in a subject. More particularly, embodiments herein relate to compounds including naturally occurring and synthetic compositions having alpha-1 antitrypsin activity but no significant serine protease inhibitor activity. | 2008-10-23 |
20080261870 | Use of the Pro-Peptide Domain of Lysyl Oxidase as a Therapeutic Agent - A therapeutic composition that includes an active portion of the lysyl oxidase pro-peptide in a pharmaceutically acceptable carrier substance and methods of using such a therapeutic composition are disclosed. The active agent does not have lysyl oxidase enzymatic activity. Preferably, the active polypeptide is active in inhibiting cell growth in soft agar and active in inhibiting tumor formation. In addition, the active polypeptide preferably comprises an active portion of the amino acid sequence given in SEQ ID NO.: 1 or SEQ ID NO.: 2, or conservative substitions thereof. Alternatively, the active polypeptide comprises a polypeptide comprising an active portion of an amino acid sequence selected from the group consisting of SEQ ID NOs.: 3-8, or conservative substitions thereof. | 2008-10-23 |
20080261871 | Y2/Y4 Selective Receptor Agonists for Therapeutic Interventions - Y receptor agonists which are selective for Y2 and Y4 receptors over the Y1 receptor are useful for treatment of, for example obesity, are (a) PP-fold peptides or PP-fold peptides mimics which have (i) a C-terminal Y receptor-recognition amino acid sequence represented by —X-Thr-Arg-X | 2008-10-23 |
20080261872 | Use of Ghrelin and Unacylated Ghrelin Compositions in Insulin-Related Disease Conditions - A novel combination of ghrelin and unacylated ghrelin is described herein. Methods of administering and uses of this combination to alter an insulin-associated parameter are also described. Compositions and packages containing ghrelin and/or one of its analogs and nonacylated ghrelin and/or one of its analogs as well as the uses of such compositions in providing therapeutic benefit to human patients diagnosed with for example insulin resistance, diabetes and obesity are described. | 2008-10-23 |
20080261873 | Growth-Hormone Secretagogues - Disclosed are methods of treating a disorder of the stomach, intestine or duodenum in a human subject. The method includes administering to the subject, a pharmaceutical composition comprising a compound that increases gastrointestinal motility (e.g., by modulating myenteric nerve activity) and/or induces the secretion or production of growth hormone. | 2008-10-23 |
20080261874 | Mutants of Trichosanthin With Anti-Tumor Activity and Lowered Side-Effects - The invention provides the mutants and coding genes of trichosanthin (TCS). The mutants thereof are the TCS mutants with the single or double alternation of tyrosine-55 and aspartate-78 (counted from N-terminus), wherein the tyrosine-55 is mutated to an aliphatic amino acid and aspartate-78 is mutated to an amino acid with low hydrophilicity. This invention also relates to the application of TCS mutants and their coding genes in the drug development to treat carcinoma, AIDS and other diseases. | 2008-10-23 |
20080261875 | Method For Treating Cardiovascular Disease - A method for treating cardiovascular disease comprising administering an effective amount of FGF-21 or an FGF-21 compound to a patient in need thereof. | 2008-10-23 |
20080261876 | Method for Purifying Marine Collagen and the Processing Thereof Into Porous Sponges - Methods are provided for purifying marine collagen and for processing the collagen into porous sponges. Products produced with these methods and the use of the products are also provided. | 2008-10-23 |
20080261877 | Albumin Fusion Proteins - The present invention encompasses albumin fusion proteins. Nucleic acid molecules encodings the albumin fusion proteins of the invention are also encompassed by the invention, as are vectors containing these nucleic acids, host cells transformed with these nucleic acids vectors, and methods of making the albumin fusion proteins of the intention and using these nucleic acids, vectors, and/or host cells. Additionally the present invention encompasses pharmaceutical compositions comprising albumin fusion proteins and methods of treating, preventing, or ameliorating diseases, disorders or conditions using albumin fusion proteins of the invention. | 2008-10-23 |
20080261878 | Method of inducing the formation of neurofibrillary tangles in transgenic animals - The present invention discloses a method and an in-vivo assay system useful for the identification and testing of modulating agents as well as for the validation of therapies of neurodegenerative diseases associated with the formation of neurofibrillary tangles, in particular Alzheimer's disease. The present invention is based on the surprising-finding that injection of β-amyloid Aβ | 2008-10-23 |
20080261879 | Method of inducing and maintaining neuronal cells - The present invention makes available a method for inducing neuronal differentiation and preventing the death or degeneration of neuronal cells both in vitro and in vivo. The subject method stems from the unexpected finding that, contrary to traditional understanding of neural induction, the default fate of ectodermal tissue is neuronal rather than mesodermal and/or epidermal. In particular, it has been discovered that preventing or antagonizing a signaling pathway in a cell for a growth factor of the TGF-β family can result in neuronal differentiation of that cell. | 2008-10-23 |
20080261880 | Synthetic approach to designed chemical structures - This invention relates to the chemical design and production of peptides, peptide structure and three dimensional conformation was assessed using NMR, circular dichroisin and pulsed field gradient NMR. In addition, this invention relates to peptides produced by these methods and to methods for using the peptides. | 2008-10-23 |
20080261881 | Use of human chorionic gonadotropin (HCG) orally or for injection for the treatment of mood disorders and alcoholism - A new use of Human Chorionic Gonadotropin (HCG) diluted as previously established for the treatment of mood disorders and alcoholism. | 2008-10-23 |
20080261882 | Methods for Inhibiting Heregulin and Treating Cancer - The present invention discloses a method using human soluble ErbB3, for example p85-sErbB3, as a negative regulator of heregulin-stimulated ErbB2, ErbB3, and ErbB4 activation. The present invention also discloses p85-sErbB3 binding to heregulin with an affinity comparable to that of full-length ErbB3, and competitively inhibiting high affinity heregulin binding to ErbB2/ErbB3 heterodimers on the cell surface of breast carcinoma cells. The present invention also uses p85-sErbB3 to inhibit heregulin-induced phosphorylation of ErbB2, ErbB3, and ErbB4 in cells, as a negative regulator of heregulin-stimulated signal transduction, and as a block for cell growth. The present invention is also directed to nucleic acids and expression vectors encoding p85-sErbB3, host cells harboring such expression vectors, and methods of producing the protein. The present invention discloses a method of therapeutically treating human malignancies associated with heregulin-mediated cell growth such as breast and prostate cancer. | 2008-10-23 |
20080261883 | RUNX3 GENE SHOWING ANTI-TUMOR ACTIVITY AND USE THEREOF - The present invention relates to a RUNX3 gene showing anti-tumor activity which is essentially involved in TGF-β-dependent programmed cell death (apoptosis) and use thereof. In addition, the present invention finds that RUNX3 gene expression is suppressed in the various gastric cancer and lung cancer cell lines. The suppression of the RUNX3 gene expression is due to hyper-methylation of CpG islands located around RUNX3 exon 1. The RUNX3 gene and its gene product of the present invention can be used effectively for the development of anti-cancer agents. The CpG islands around RUNX3 exon 1 could also be used not only for the development of anti-cancer agents which regulate the abnormal DNA methylation and thereby induce RUNX3 expression, and also for the development of methods for cancer diagnosis by measuring the abnormal DNA methylation. | 2008-10-23 |
20080261884 | Lung Volume Reduction Therapy Using Crosslinked Biopolymers - One aspect of the present invention relates to bronchoscopic lung volume reduction using solutions of biopolymers that can be polymerized in situ with a crosslinker and a polymeric additive which accelerates the cross-linking reaction. In certain embodiments, the biopolymer solutions can be in the form of a foam or gel. The biopolymer compositions disclosed herein may also be used for indications other than lung volume reduction, such as sealing fistulas or performing emergency tamponade of vessels. | 2008-10-23 |
20080261885 | PROCESS FOR THE EXTRACTION, PURIFICATION AND ENZYMATIC MODIFICATION OF SOY 7S GLOBULIN ALPHA' SUBUNIT FOR USE AS HYPOCHOLESTEROLEMIZING AGENT - A process for the extraction, purification and enzymatic modification of β-conglycinin α′ subunit, wherein β-conglycinin is selectively extracted from ground, defatted soy, then precipitated by treatment with aqueous ethanol; the enriched fraction is then subjected to Metal Affinity Chromatography (MAC) in denaturant conditions to obtain the α′ subunit, which is treated with chymotrypsin, then subjected to a further MAC to recover the amino-terminal region of this polypeptide (MW 28,000 Da). | 2008-10-23 |
20080261886 | Single-Dose Administration of Factor VIIa - The present invention provides methods for preventing and/or treating bleeding episodes by administering a single dose of a Factor VIIa equivalent. Preferably, the single dose comprises between about 150 and about 500 ug/kg Factor VIIa equivalent. | 2008-10-23 |